Oct 8, 2021
P&L%:
2.76%
Net P/L $:
$9.98
Performance Metrics
| Entry CPU | 36.25 | Price P/L $ | $0.00 |
| Exit CPU | 37.25 | Div P/L $ | $0.00 |
| Fees | $0.02 | Gross P/L $ | $10.00 |
| Reg Fees | $0.00 | Net P/L $ | $9.98 |
| Commissions | $0.02 | P&L% | 2.76% |
| Cash Div. | $0.00 | Total Ret. % | 0.00% |
| Max Qty | 10 | Open P/L $ | $0.00 |
| Current Qty | 0 | Open P&L% | 0.00% |
| Max Cost | $362.50 | Open Value | $0.00 |
Featured Image / Proof
| Price | $10.25 | Prev Close | $10.28 | Mkt Cap | $570.92M |
| Enterprise Val | $570.51M | P/E (TTM) | — | Forward P/E | — |
| EPS (TTM) | — | Forward EPS | — | Book/sh | -0.99 |
| ROE | — | Debt/Eq | — | Current Ratio | 8.13 |
| Short Interest | 1.66K | Short Float | 0.00% | Short Ratio | 0.06 |
| Avg Vol | 17.94K | Div Yield | — | Next Earnings | — |
Auto-generated Chart
Notes
FDA drugs approval.
From 18 to 37 on pre-market
Transactions
2 entries| Date | Side | Amount | Price | Commission | Exchange / SEC | Current amt | Current value |
|---|---|---|---|---|---|---|---|
| Oct 08, 2021 08:12:07 | Exit | ||||||
| Oct 08, 2021 08:11:26 | Entry |
